| LncRNA |
Compound |
Cancer |
P-value |
Effect |
| ENSG00000231889.3 |
Ponatinib |
Bladder urothelial carcinoma |
0.018364952 |
Resistant |
| ENSG00000231889.3 |
Ponatinib |
Brain lower grade glioma |
0.035042528 |
Resistant |
| ENSG00000231889.3 |
Ponatinib |
Lung squamous cell carcinoma |
0.003811798 |
Resistant |
